DK1496869T3 - Overtrukne partikler med depotvirkning og tabletter indeholdende disse - Google Patents

Overtrukne partikler med depotvirkning og tabletter indeholdende disse

Info

Publication number
DK1496869T3
DK1496869T3 DK03740656T DK03740656T DK1496869T3 DK 1496869 T3 DK1496869 T3 DK 1496869T3 DK 03740656 T DK03740656 T DK 03740656T DK 03740656 T DK03740656 T DK 03740656T DK 1496869 T3 DK1496869 T3 DK 1496869T3
Authority
DK
Denmark
Prior art keywords
coated particles
tablets containing
depot effect
film
optionally
Prior art date
Application number
DK03740656T
Other languages
Danish (da)
English (en)
Inventor
Phillippe Chenevier
Dominique Marechal
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Application granted granted Critical
Publication of DK1496869T3 publication Critical patent/DK1496869T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
DK03740656T 2002-04-23 2003-04-23 Overtrukne partikler med depotvirkning og tabletter indeholdende disse DK1496869T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0205077A FR2838647B1 (fr) 2002-04-23 2002-04-23 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
PCT/FR2003/001284 WO2003090724A1 (fr) 2002-04-23 2003-04-23 Particules enrobees a liberation prolongee et comprimes les contenant

Publications (1)

Publication Number Publication Date
DK1496869T3 true DK1496869T3 (da) 2009-06-22

Family

ID=28686298

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03740656T DK1496869T3 (da) 2002-04-23 2003-04-23 Overtrukne partikler med depotvirkning og tabletter indeholdende disse

Country Status (15)

Country Link
US (1) US7718194B2 (de)
EP (1) EP1496869B1 (de)
JP (1) JP4652693B2 (de)
CN (1) CN1655767B (de)
AT (1) ATE422879T1 (de)
AU (1) AU2003262812A1 (de)
CA (1) CA2483212C (de)
DE (1) DE60326219D1 (de)
DK (1) DK1496869T3 (de)
ES (1) ES2321921T3 (de)
FR (1) FR2838647B1 (de)
HK (1) HK1072014A1 (de)
PT (1) PT1496869E (de)
SI (1) SI1496869T1 (de)
WO (1) WO2003090724A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
BRPI0609505A2 (pt) * 2005-03-29 2010-04-13 Rihm Gmbh forma farmacêutica em multipartìculas compreendendo péletes com uma matriz que influencia o fornecimento de uma substáncia moduladora
US8187659B2 (en) 2006-05-02 2012-05-29 Jerry Robertson Real Estate Llc Solid medicament dosage form consumption aid
FR2959130A1 (fr) * 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
CA2991216C (en) 2010-12-22 2020-04-28 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
ES2581323T3 (es) 2010-12-23 2016-09-05 Purdue Pharma Lp Formas de dosificación oral sólida resistentes a alteraciones
CN102697660B (zh) * 2012-06-04 2014-02-12 贵州景峰注射剂有限公司 一种去除微丸丸间静电的方法
US8888480B2 (en) 2012-09-05 2014-11-18 Aprecia Pharmaceuticals Company Three-dimensional printing system and equipment assembly
BR112015017451B1 (pt) 2013-02-05 2023-01-10 Purdue Pharma L.P. Formulações farmacêuticas resistentes à violação
US20140230769A1 (en) * 2013-02-15 2014-08-21 GM Global Technology Operations LLC Polymeric engine component having integrated oil additive
US9339489B2 (en) * 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
JP6466399B2 (ja) 2013-03-15 2019-02-06 アプレシア・ファーマスーティカルズ・カンパニー トピラマートの急速分散性の剤形
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
JP6392355B2 (ja) 2013-09-13 2018-09-19 アール．ピー．シェーラー テクノロジーズ、エルエルシー ペレット包含錠剤
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
AU2015209674B2 (en) * 2014-01-21 2018-11-08 Bpsi Holdings, Llc Immediate release film coatings containing medium chain glycerides and substrates coated therewith
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
JP2017531026A (ja) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 徐放性乱用抑止性液体充填剤形
WO2016205754A1 (en) 2015-06-19 2016-12-22 University Of Southern California Compositions and methods for modified nutrient delivery
WO2016205701A1 (en) 2015-06-19 2016-12-22 University Of Southern California Enteral fast access tract platform system
BR112018001609A2 (pt) 2015-08-21 2018-09-18 Aprecia Pharmaceuticals LLC sistema e montagem de equipamento de impressão tridimensional
CN112391152B (zh) * 2019-08-13 2022-11-25 中国石油化工股份有限公司 一种固井封堵材料及其制备方法和应用
CN111772187B (zh) * 2020-07-02 2023-04-07 吕剑 一种酸杨桃提取物及其提取方法及其制品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598458A (en) 1977-04-01 1981-09-23 Hoechst Uk Ltd Tableting of microcapsules
KR100264547B1 (ko) * 1994-04-26 2000-12-01 나가야마 오사무 수크랄페이트의용융조립제제및그의제조방법
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
CA2322315C (en) * 1998-03-06 2008-09-16 Eurand International S.P.A. Fast disintegrating tablets
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors

Also Published As

Publication number Publication date
JP2005532300A (ja) 2005-10-27
FR2838647B1 (fr) 2006-02-17
FR2838647A1 (fr) 2003-10-24
JP4652693B2 (ja) 2011-03-16
HK1072014A1 (en) 2005-08-12
CA2483212C (fr) 2012-10-02
ES2321921T3 (es) 2009-06-15
WO2003090724A8 (fr) 2004-11-04
PT1496869E (pt) 2009-05-06
US7718194B2 (en) 2010-05-18
ATE422879T1 (de) 2009-03-15
CA2483212A1 (fr) 2003-11-06
EP1496869A1 (de) 2005-01-19
CN1655767A (zh) 2005-08-17
DE60326219D1 (de) 2009-04-02
CN1655767B (zh) 2011-04-20
EP1496869B1 (de) 2009-02-18
US20050152976A1 (en) 2005-07-14
WO2003090724A1 (fr) 2003-11-06
AU2003262812A1 (en) 2003-11-10
SI1496869T1 (sl) 2009-06-30

Similar Documents

Publication Publication Date Title
DK1496869T3 (da) Overtrukne partikler med depotvirkning og tabletter indeholdende disse
NO913524D0 (no) Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav.
NO20072839L (no) 4-hydroksybenzomorfaner
EP1594454A4 (de) Film-bildender hydroalkoholischer schaum
NO965540L (no) Preparat omfattende morfin, polypyrrolidon og et polyalkylenoksid
TR199800794T2 (xx) Sinerjistik herbisid kar���mlar�.
WO2005074441A3 (en) Method and system for customizing views of information associated with a social network user
FR2766089B1 (fr) Comprime multiparticulaire perfectionne a delitement rapide
NO995313L (no) Mikroartikler nyttige som ultrasoniske kontrastmidler og til levering av legemidler i blodbanen
TR199501613A2 (tr) Ince filmler ve film/örülmemis laminatlar.
NL193930B (nl) Inhaleerinrichting met verpakking voor medicijn in poedervorm alsmede een dergelijke medicijnverpakking.
ES2196620T3 (es) Formulacion de liberacion prolongada que contiene venlafaxina.
MXPA03005471A (es) Peliculas de poliuretano elasticas y con capacidad para respirar y laminados que contienen las mismas.
AU2003203000A1 (en) Laser weldable flexible medical tubings, films and assemblies thereof
AU2003268040A1 (en) Methods, systems, and computer readable media containing instructions for evaluating the return on direct mail marketing
DE29510554U1 (de) Persönliches Mitteilungsübertragungs- und Empfangssystem für Mehrfachbenutzer
DE69529738T2 (de) Polystyrolharzzusammensetzung, sowie orientierter polystyrolfilm
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
MX9909797A (es) Composiciones para el cuidado personal que comprenden un copolimero adhesivo.
FR2855408B1 (fr) Composition deodorante aerosol alcoolique contenant le salicylate de zinc ou l'un de ses derives
DK1053446T3 (da) Patronhylster med et beskyttende spærrelag
NO993384L (no) Avtagbar beskyttelsesfilm for virkestoffholdige plastersystemer, spesielt selvklebende plastersystemer
Lemmens Marketing in Research and Development The Role of the" Innovation Navigator" Marketing in the Management ofResearch Institutions and EnterprisesInvolved in Research
IT1313320B1 (it) Procedimento di termorestrizione per materiali termoretraibili,particolarmente per film plastici e simili.
DE69615340D1 (de) Antimykotische zusammensetzung welche crotamiton und salicylaldehyd enthält